Results 141 to 150 of about 836,416 (221)

Tumor-infiltrating lymphocyte immunotherapy comes of age: a journey of development in the Surgery Branch, NCI. [PDF]

J Immunother Cancer
Goff SL, Rosenberg SA.
europepmc   +1 more source

Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma. [PDF]

Cancer Biol Med
Yu T, Wang X, Bai O, Zhang H, Qian W.
europepmc   +1 more source

Immunotherapeutic Approaches to Peanut Allergy Treatment-Pre-Clinical and Clinical Studies: A Comprehensive Review. [PDF]

J Clin Med
Gunawardhana K, Raygoza PM, Yang C, Mohamed E.   +3 more
europepmc   +1 more source

Meet the T Cell Antigen Receptor

The American Biology Teacher, 1990
openaire   +2 more sources

Strategies to Overcome Antigen Heterogeneity in CAR-T Cell Therapy. [PDF]

Cells
Zhang B, Wu J, Jiang H, Zhou M.
europepmc   +1 more source

Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment. [PDF]

Antibodies (Basel)
In H, Park M, Lee H, Han KH.
europepmc   +1 more source

Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies. [PDF]

Front Immunol
Nair R, Somasundaram V, Kuriakose A, Krishn SR, Raben D, Salazar R, Nair P.   +6 more
europepmc   +1 more source

Maternal IgE Influence on Fetal and Infant Health. [PDF]

Immunol Rev
Balla J, Rathore APS, St John AL.
europepmc   +1 more source

Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors

Nature Reviews Clinical Oncology, 2013
J. Kochenderfer, S. Rosenberg
semanticscholar   +1 more source

Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy. [PDF]

Front Immunol
DiAndreth B, Nesterenko PA, Winters AG, Flynn AD, Jette CA, Suryawanshi V, Shafaattalab S, Martire S, Daris M, Moore E, Elshimali R, Gill T, Riley TP, Miller S, Netirojjanakul C, Hamburger AE, Kamb A.   +16 more
europepmc   +1 more source